An unconventional dose of epinephrine for a diagnostic test of catecholaminergic polymorphic ventricular tachycardia: A case report
Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a rare heritable arrhythmogenic disease, and the Mayo Clinic protocol-guided epinephrine test is commonly used for diagnostic purposes. Whether the Mayo Clinic protocol is enough for patients who are insensitive to catecholamine remains an unknown question. Our patient was a19-year-old female who presented with recurrent stress-induced syncope and was saved by cardiopulmonary resuscitation. The initial physical examination and complementary tests (ECG, blood laboratory, cardiac ultrasound, and cranial magnetic resonance angiography) showed no abnormalities on admission. Treadmill exercise testing shows non-sustained and polymorphic tachycardia. A subsequent epinephrine test was performed, and polymorphic ventricular tachycardia was not induced until using a high dose of epinephrine above Mayo Clinic protocol. Therefore, it is suggested that an unconventional dose of epinephrine may be needed fordiagnostic tests of CPVT for some insensitive individuals.
- Van der Werf C, Zwinderman AH, Wilde AA, 2012, Therapeutic approach for patients with catecholaminergic polymorphic ventricular tachycardia: State of the art and future developments. Europace, 14: 175–183. https://doi.org/10.1093/europace/eur277
- Vyas H, Ackerman MJ, 2006, Epinephrine QT stress testing in congenital long QT syndrome. J Electrocardiol, 39: S107–S113. https://doi.org/10.1016/j.jelectrocard.2006.05.013
- Kim NY, Kang JK, Park SH, et al., 2012, Catecholaminergic polymorphic ventricular tachycardia in a patient with recurrent exertional syncope. Korean Circ J, 42: 129–132. https://doi.org/10.4070/kcj.2012.42.2.129
- Vyas H, Hejlik J, Ackerman MJ, 2006, Epinephrine QT stress testing in the evaluation of congenital long-QT syndrome: diagnostic accuracy of the paradoxical QT response. Circulation, 113: 1385–1392. https://doi.org/10.1161/CIRCULATIONAHA.105.600445
- Krahn AD, Healey JS, Chauhan VS, et al., 2012, Epinephrine infusion in the evaluation of unexplained cardiac arrest and familial sudden death: From the cardiac arrest survivors with preserved ejection fraction registry. Circ Arrhythm Electrophysiol, 5: 933–940. https://doi.org/10.1161/CIRCEP.112.973230
- Leenhardt A, Denjoy I, Guicheney P, 2012, Catecholaminergic polymorphic ventricular tachycardia. Circ Arrhythm Electrophysiol, 5: 1044–1052. https://doi.org/10.1161/CIRCEP.111.962027
- Laitinen PJ, Brown KM, Piippo K, et al., 2001, Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia. Circulation, 103: 485–490. https://doi.org/10.1161/01.cir.103.4.485
- Lahat H, Pras E, Olender T, et al., A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel. Am J Hum Genet, 69: 1378–1384. https://doi.org/10.1086/324565
- Rosso R, Kalman JM, Rogowski O, et al., Calcium channel blockers and beta-blockers versus beta-blockers alone for preventing exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm, 4: 1149–1154. https://doi.org/10.1016/j.hrthm.2007.05.017
- Watanabe H, Chopra N, Laver D, et al., 2009, Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans. Nat Med, 15: 380–383. https://doi.org/10.1038/nm.1942